News Archive
Michael J. Whalen, MD, discusses the newly updated prostate screening guidelines set forth by the U.S. Preventative Services Task Force.
Gaby Moawad, MD, FACOG, explains the most common minimally invasive gynecologic surgeries, including hysterectomy, removal of fibroids and ovarian cysts, endometriosis, and prolapse correction, as well as the benefits (fewer complications, faster recovery).
Rachel F. Brem, MD, FACR, FSBI, discusses the various breast cancer screening options (mammography, ultrasound, MR, molecular breast imaging) and clears up some of the confusion surrounding the current mammography recommendations.
Dr. Rachel Brem and Liz Lord, both breast cancer survivors, co-authored this piece on why mammograms are vital and how GW is bringing them directly to patients.
Eight George Washington University alumni will be honored this year with the Distinguished Alumni Achievement Award, the highest form of recognition given annually by the university and the George Washington Alumni Association to a graduate.
Vincent Obias, MD, FACS, FASCRS, describes the benefits of minimally invasive colorectal surgery, whether laparoscopic or robotic.
Keith D. Mortman, MD, FACS, FCCP, discusses the option for lung cancer screenings of those at high risk of developing the disease, including people who are 55 to 77 years old, have smoked at least a pack of cigarettes a day for the last 30 years, have quit smoking within the past 15 years, and…
Mandi Pratt-Chapman, MA, associate center director for patient-centered initiatives and health equity at GW Cancer Center, accepted a check from the Avon Foundation at the annual Avon Walk in Washington, D.C. The money will fund a patient navigator who will provide resources to help breast…
A team of researchers at GW Cancer Center found that T-cells lacking in the HDAC11 enzyme performed better in attacking cancer tumor cells. This research highlights the importance of treating HDAC11 as an immunotherapeutic target.
Norman Lee, PhD, professor of pharmacology and physiology, published research in Nature Communications finding that a form of genetic variation, called differential RNA splicing, may have a role in tumor aggressiveness and drug resistance in African American men with prostate cancer.